11/11/2022 0 Comments Risk 2 download chip![]() ![]() Participants were insulin manufacturers, drug wholesalers, pharmacies, pharmacy benefit managers, and health plans. Objective To estimate the share of net expenditures on insulin captured by manufacturers, wholesalers, pharmacy benefit managers, pharmacies, and health plans from 2014 to 2018.ĭesign, Setting, and Participants This cross-sectional study of the US insulin market was conducted in 2020 using 2014-2018 data from multiple sources, including list and estimated net prices from SSR Health for 32 insulin products, mean use weights from a commercial pharmacy claims database, mean acquisition costs and reimbursements from the Centers for Medicare & Medicaid Services, mean spread and share of rebates retained by pharmacy benefit managers from state Medicaid and drug transparency reports, and profit margins from the public filings of distribution system participant companies. Importance Recent US media and policy attention on insulin affordability has focused on the role of manufacturers in setting prices however, the role of other drug distribution intermediaries in determining prices has received less attention.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |